Home › NCT06815367
Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery
Comparing the Effects of Pneumatic Compression and Blood Flow Restriction Therapy on Muscle Recovery
Who can join
Ages 18 to 30 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 18-30 years of age * Recreationally active population * Women should be on a form of hormonal contraception. * No current musculoskeletal injuries or pathologies * Must answer "yes" to all PAR-Q questions. Exclusion Criteria: * Individuals that routinely train trail running * Discomfort when running * Deep vein thrombosis * Blood clots * Cancerous lesions * Sensory or mental impairment * Unstable fractures * Acute pulmonary edema * Acute thrombophlebitis * Acute congestive cardiac failure * Acute infections * Episodes of pulmonary embolism * Wounds, lesions, infection, or tumors * Bone fractures or dislocations * Increased venous and lymphatic return * Answers "no" to any of the PAR-Q screening questions
About the study
Both BFR and intermittent pneumatic compression are purported to decrease symptoms associated with exercise induced muscle damage (EIMD) that cause delayed onset muscle soreness (DOMS). Blood flow restriction relies on applying pressurized cuffs to the most proximal portion of the limb. Another form of recovery often relied upon is pneumatic compression. The mechanism by which pneumatic compression works is similar to that of a massage, whereby the device progressively increases the pressure on a portion of the limb before releasing and moving further up the limb.The purpose of this study is determine whether BFR or pneumatic compression can be used to decreased DOMS which may indicate enhanced recovery.
What is being tested
- Pneumatic Compression (device)
- Blood Flow Restriction (device)
Sponsor: University of Southern California · Participants: 33 · Started: Jan 15, 2024
Contact the study team
- Bailey McLagan, MS · Phone: 323-442-2498
Official record on ClinicalTrials.gov — NCT06815367
Locations in the U.S.
| California | University of Southern California, Los Angeles |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.